In another European cohort (26), IgA anti-CD74 were present in 54.7% of axSpA patients and 46.2% of CBP patients while IgG anti-CD74 were present in 46.4% of axSpA patients and 37% of CBP patients (26). This evidence concerns the gene CD79A and red color blindness.